Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Denmark
Sweden
Finland
Norway
Latest
Trending
Followed

Beijer Alma, Audiocast with teleconference, Q1'24

By Inderes4/26/2024, 8:00 AM
Beijer Alma

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Speaker 1
00:00 - 11:29

Good morning, everybody, and welcome to our webcast, where we will today present our first quarter 2024. My name is Andrew Purbeck, and with me, I have our CFO. We own the market. Good morning. Today, we will present the overall performance of our group. In addition, we will also discuss our reporting segments and our two main subsidiaries. And these are Leisure Focus, which is a full-service supplier of standard and customized industrial springs and other wire and flat strip components. This report is acting globally with the majority of sales in Europe and the US. And then the other, Biotech, acts mainly in the Nordics within specialized manufacturing, adding value through industrial trading and automation in profitable niches. Biotech is also a platform for acquisitions into new industrial niches. So starting off with some comments from my side. Today, I will present to you what I think is a fairly good report, given the world around us and where we are in the business cycle. We saw our first quarter with strong development in chassis springs and several other niches. Overall for the group. We had some growth, both organically and thanks to acquisitions. Of course, demand was still quite varied within our very diversified customer base. We saw automotive, aftermarket, medical technology, and other niches posted good growth, whereas broad industrial segments were softer. In the first quarter, we saw mixed demand between customer segments and geographies. As mentioned, Chassis Springs business area posted good growth and is now in high season. And this was driven by strong end-customer demand, normalized inventory levels, and also our high delivery speed and service level. Within industrial springs. The Nordics, UK, US, and also Asia contributed some organic growth. Not a lot, but still, in Central Europe, however, the demand was weaker in relation to general industrial and construction activity. But perhaps most importantly for us, we could see the sequential improvement of margins compared with previous quarters. And this is thanks to actions taken, but also favorable mix effects. Well, in the Nordics. Demand was generally stable and as you will have seen in the report, Biotech is now presenting a new business area called Niche Technologies. And this is actually the area that is delivering high growth in this quarter thanks to a combination of acquisitions and organic growth. Fluid technology and industrial products experience. The Swedish market and Norwegian market stood out more positively and contributed growth, whereas for example, Finland was somewhat weaker, partly due to the indirect effects of the strikes. In the quarter, we also completed one new acquisition. AWS Power in Finland. ABS is a leading wholesaler and manufacturer of pneumatics, industrial valves, and compressors, and we think the company fits very well into basic fluid technology, with also potential for cooperation within the Nordics. And generally, the activity level within M&A is good, and we can see several opportunities in our pipeline. Um, having said that, the business cycle and the operating environment are still uncertain, and we will balance investments for growth with savings. So looking into our, um. Financial performance of the group. And looking at the performance, we can see that order bookings grew by 4% but were down 4% organically. And this is not so dramatic. And I will comment on this in more detail. Uh, when speaking about biotech, um, the net revenues grew by 7%, of which 3% was organic, uh, which I think better mirrors the demand we are experiencing in the market. And, uh, also worth pointing out, um, which cannot be seen on this graph, actually, but we have reached 7 billion in net revenues over the last 12 months. And that's a kind of milestone, um. During the quarter, um, demand has been fairly stable and healthy since the start of the year. Um, and certainly better than the end of Q4. Um, the comparables for Q1 last year are fairly strong. Um, and not the least since March this year had three trading days less, um, than last year due to early Easter. And of course, this should come back in April. But. But still. Um. So, adjusted operating profit was 242 million kroner, with a margin of 13.3%. So moving on to the performance of the reporting segments. Starting with, um, let's focus on our spring manufacturer. Let's focus organized into two business areas. Um, these are industry, uh, with mainly customized products to a very diversified customer base globally. And chassis springs that are standardized replacement springs sold to corporate wholesalers, mainly in Europe, and you can see the share of revenues down on the right, where chassis springs are a little bit more than a fifth this quarter. Um. Or the bookings for leisure offers um, 6% increase, uh, of which 3% is organically. And that revenue also grew by 6%, where 5% was organically, uh, with chassis springs being the key growth driver, of course. But starting with the industry, um, the largest business area, uh, growth was 3% and mainly organic. Um, since the net of acquisitions and divestments this, this quarter, uh, were neutral. As mentioned, volumes grew somewhat in the Nordics, UK, US, and Asia, um in Central Europe, including alchemists. The operating environment remained tougher, and uh, demand was affected by lower industrial and construction activities. Results of spring's net revenues increased by 19% thanks to good demand during the first quarter, and we have now entered the high season, and inventory levels at wholesalers were estimated to be normalized at the beginning of the quarter, and end consumer demand drove volumes in all key markets. Adjusted operating profit for Lesotho increased to 200 million, within the EBIT operating margin in the quarter of 15.8%. And as you can see, top right, the operating margin improved sequentially versus preceding quarters, almost reaching the level of last Q1. And this is an improvement, of course. And thanks to product mix effect, but also several actions taken. For example, the divestment in December of a German subsidiary which had a slightly positive effect. Moving over to the topic at hand. So basically, since the beginning of this year, operating in three business areas: fluid technology, industrial products, and both acting within industrial trading and manufacturing. The third business area, A new one, is called Niche Technologies, which includes companies with strong market positions in various industrial niches such as building automation, waste management, and specialized machinery. And typically these companies have other market drivers than more general industrial demand.

For biotech, overall, order bookings decreased in the quarter by 1%, of which -21% organically. Now, this negative organic growth in the order book does not really mirror the demand we're seeing in the market. And order bookings, in fact, are higher than net revenues in the quarter. Instead, this -21% is related to very high comps last year. And some of you might remember that when we, a year ago, showed 25% organic growth, it was actually attributed to certain specific projects. So, trading wise and as I said, book 2 billion is positive. So, net revenue grew by 9%, of which 2% was organic. And here, of course, we can see some negative calendar effects towards the end of the quarter in March. Now, within the business area, industrial products and fluid technology demand was overall stable, but on the weaker side, with slightly declining volumes. As mentioned, Norway stood out as stronger, whereas Finland was weaker. We did not actually have any direct effects of the strikes, but several of our customers had, so industrial products decreased net revenues by 6% versus last year, and fluid technology grew by 3%. In the new business area, Niche Technologies, Growth came both from acquisitions, which now is only for Nomics in this quarter, but also organic growth. So in total, growth of 51%. Paychecks' operating result decreased to 49 million kronor. But here I want to point out that it did include some acquisition costs late in the quarter, including Finnish transaction tax. So the reported 9% operating margin isn't such a trend down; the underlying margin would be well above 10%. Adjusting for that. But now I will hand over to you for some more comments on the financials.

Henrik
11:30 - 15:14

Thank you, Henrik. As mentioned, net revenue is up 119 million compared to last year. The largest part of this is due to acquisitions together with divestments, which contributed with 60 million. And it's equal to an increase of 4%, while organic growth was 3%. Local force had an organic growth of 5%, mainly affected by strong sales in the Cross Springs business area, and biotech had a negative organic growth of -2%. As Henrik mentioned, this was in effect from general demand, calendar effect, and as well as strikes in Finland. There was also a small positive effect from currency in the quarter. Order bookings increased by 68 million to 1876 million SEK. Acquisitions were positive 7%, while organic growth was -4%. And as Henrik mentioned, the main reason for the fact that order bookings were negative was that, with very strong comparables in biotech from last year, but orders related to projects were delayed from the previous year. The fourth had a positive organic growth in order bookings of plus 3%. Let's continue with a short look at the segments and how they contribute to revenue and operating results. As we saw in the previous slide, net revenue increased by 119 million to 1812 million SEK. We had an increase from all three factors: organic growth, net effect from acquisitions and divestments, and as well currency. Well, the biggest factor for the growth in labor force was organic growth was related to acquisitions. Adjusted operating profit was $242 million in Q1. The increase compared to last year was, among other things, related to Cross Springs, which also is in the high season but a somewhat more challenging environment in Central Europe. The less positive operating result was affected by acquisition costs of -7%. Adjusted for this, biotech was on par with last year. Underlying, we see a strong development for the companies within niche technology and portfolio technology, but the soft demand for some of the companies within industrial products. These companies also experienced a strong calendar effect compared with last year. We did as well reverse an additional 2 million from the Russia closed-down provision that we made in 2022, which is the difference between adjusted and unadjusted EBIT. Now to some of the key financial ratios. Adjusted EBITDA is up 4 million compared to last year. The difference to adjusted EBIT being higher depreciation following a number of acquisitions. Cash flow from capital expenditure was -38 million, almost in line with last year. The negative cash flow is mainly related to seasonal effects, especially within Cross Springs. Overall, we are satisfied with the development of the working capital. Even though the seasonality effect in Q1 takes a little more capital. Net debt is higher than last year, and this is related to acquisitions and most recently, the acquisition of Obvious Power in Finland. The financial net has improved compared to last year. A small part of the improvement is related to more efficient use of cash, but also there are some positive currency effects in the quarter.

Unknown
15:16 - 15:16

Thank you.

Henrik
15:16 - 15:22

And back to Henrik for a continued look at acquisitions and also sustainability.

Unknown
15:24 - 15:25

Yes.

Speaker 1
15:25 - 20:12

So, um. Just two comments on our acquisition strategy as we continue to, um, further grow by acquisitions. During the spring, we have seen good activity in the M&A market, and we have discussions with several good companies in our pipeline. Last year, the acquired companies added over half a billion to our run rate revenue with good profitability. And now in 2024, one new company has been added, uh, to contribute to profitable growth. And here I would also like to take the opportunity to welcome Matt and the whole ABS team to our group. Now, on a bit different note, during this webcast, I would like to mention some of the highlights from our sustainability report, which was published recently together with our annual report. Um, we set our sustainability targets five years ago and have now reached the end of that goal period. Um, and I will not go through everything here, but overall, I think we have developed, um, very well as a group in many of these areas. Um, and in particular, I want to point out, uh, in terms of climate impact. As you can see in the middle of this busy slide, um, we have reduced our carbon intensity by 55% during these years, well above the target of 25%. And this is driven by a range of activities, uh, such as and most importantly, reduced energy consumption by 36%. But also a larger share of renewable energy, solar panels, and transition to bio-based, bio-based fuel. So good progress. Um, during these years. Um, so now we move over to a new target period. And we're now setting ambitious targets for the future and the year 2030. These are now aligned with. That we have set so-called science-based targets for reducing our climate impact. And 2030 is what is called our near-term target. Here it is not only our own impact that matters, but the climate impact from the whole value chain and significant improvements can only be achieved through close partnership with our customers and suppliers. And of course, at the same time we will continue to focus on reducing our own footprint. Also in other sustainability areas, we must work closer with our value chain. One example is within business ethics. Now where we have started steps with our business partner code of conduct, and over time we'll develop a closer due diligence process of suppliers. Also in conjunction with the development of the legislation in this field. Further, we must use resources such as energy and materials more efficiently. For this, we will develop circular solutions for waste, but perhaps even more importantly, to bring sustainability into our innovation and design process. Then we can really add value to our customers and their strive to reduce the impact from their final products. A new journey ahead. So now just summarizing what we said regarding Q1. Growth this quarter came in particularly from chassis springs and industrial niches, but demand was varied and the broader industrial segments were softer. In Leicester, Bosch's strong performance in chassis springs and Nordic UK, US, and Asia contributed some organic growth, whereas we saw weaker demand in Central Europe and an anomaly in relation to general industrial and construction activity.

Also, for Leicester, sequentially improved margins and recovery from the end of last year. In that sense, for the new business area. Niche technologies contributed growth and industrial trading was particularly strong in Norway, a little bit weaker in Finland. And underlying margins remained stable. And finally, our new acquisition of ABS Power in Finland, a good fit into biotech fluid technologies. So with that, we will open up for some questions.

Unknown
20:15 - 20:37

If you wish to ask a question, please dial Pound Key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial Pound Key six on your telephone keypad. The next question comes from Carl Nolan from SEB. Please go ahead.

Unknown
20:40 - 21:02

Hello and good morning, Henrik and Johan. A couple of questions from my side. Maybe if we start off with the chassis springs. I mean, quite a strong quarter. I think the best Q1 ever. I didn't really catch what they said there on the normalized inventory levels. Did they say that they were normalized at the beginning of the quarter and at the end of the quarter? So some comments around that would be helpful. Thank you.

Speaker 1
21:06 - 22:17

And good morning, Carl. That's a good question. So I did, in fact, say it was normalized at the beginning of the quarter, meaning that, first of all, a year ago we had some strong effects on inventory reduction still from the supply chain issues. But then in the high season in general, there is a natural build-up of inventory with our wholesalers. So, of course, we have good sales now when we're entering the high season. And part of that is, of course, also the fact that they have increased demand and they are building up stock for the season. So you could also say that it has been normalized levels in the quarter. No, nothing particular there. It's more about the end consumer demand. And that is driving it, and also, as I wanted to point out, the fact that we have a service model that is very strong in the market so we can respond quickly and we do, in fact, build up stock as, as you once said, also, we tie up a bit more capital in the first quarter in order to meet the spring demand. So it's also a part of our business model to really be able to respond to this. Um, so, yeah, a very good quarter indeed.

Unknown
22:17 - 22:18

And yeah.

Unknown
22:19 - 22:37

Good. And on biotech then, a little bit weaker margins there than what we're used to in the last quarter. So can you help us understand if it's more a blip on the curve driven by some calendar effects or maybe impact constraints in Finland, or if there is some, let's say, company-specific issues in some of the subsidiaries.

Speaker 1
22:40 - 23:28

Well, first of all, I want to once again just reiterate the fact that we did get this M&A cost late in the quarter, meaning that we had very little contribution from that acquisition in terms of profitability, but the full cost of that transaction. And so, you know, say for that, the margin level is around 10.3%, which I think is absolutely fine for biotech. Um, we do see, as mentioned, a little bit softer markets in the industrial trading. And, and you can see the industrial products are down by 6%. And of course, that matters as well. So, um, I think nothing that stands out as such. Uh, but, you know, we are still in a market, which is, um, you know, fairly flat.

Unknown
23:31 - 23:32

Yeah. That's clear.

Speaker 1
23:32 - 23:38

And as you said, the calendar days at the end of the quarter were part of the effect.

Unknown
23:38 - 23:38

Yes.

Unknown
23:38 - 23:43

That's an impact on profitability a little bit, one extra workday, etc.

Unknown
23:44 - 23:45

Uh, but that's good.

Unknown
23:45 - 24:11

And then there's the question on the M&A as well. I mean, in the report, you say that they have a good pipeline and are in discussion with several targets. But you also mentioned, you know, there is high uncertainty, etc., high interest rates. I mean, you want to hear your view on your balance sheet and the ability to take on more acquisitions in the near term. Uh, and what to expect. I mean, you mentioned 0.5 billion in M&A during 2023. Is that also possible for 2024? I think.

Speaker 1
24:14 - 25:15

And yes. So first of all, on the market, as I mentioned, we have just you know, it's been very interesting that there is a lot of activity. Um, of course, you know, when looking into companies in these, uh, what should we say, these times, you know, you need to evaluate what is the performance of the company. And, you know, there's maybe less growth. So, it's a matter of meeting, you know, buyer and seller in a good way. But, there are plenty of interesting opportunities. I think, yes, I think we do have the capacity for a similar amount of acquisitions this year with our debt ratio. So, that is not holding us back. But, we will continue to be selective, choosing very good companies to work with because we're in it for the long term, forever hopefully. So, we really want to make sure we acquire the right companies. But, in terms of financial capability, we should be able to achieve similar numbers.

Unknown
25:16 - 25:17

Yeah. Good.

Unknown
25:17 - 25:19

That's all for me. Thank you.

Unknown
25:21 - 25:21

Thank you. Car.

Unknown
25:24 - 25:30

The next question comes from Johan Dahl from Danske Bank. Please go ahead.

Unknown
25:31 - 25:32

Come on.

Unknown
25:32 - 25:34

Yes. Good morning, everyone. Can you hear me? Yeah.

Unknown
25:36 - 25:36

Good morning. Yes.

Unknown
25:36 - 25:37

Good morning.

Unknown
25:37 - 26:09

Yeah. Just on your order intake, you reported up 3% organically in the quarter. And obviously, we have this issue with the shops selling houses and good end-user demand there. But, on the industrial side of order intake, are you seeing any sort of trend shifts there? You talk about the UK being a bit better. I'm just trying to pin down whether this market could be close to bottoming out or if you're seeing any cross-selling impact here.

Speaker 1
26:11 - 27:47

Good question. If we start on the market side, I mean, the numbers are not big in any direction, as you know, 3% up. And we have an effect, of course, also from Shasta Springs. So, I think last quarter we reported that the Nordic was a little bit softer. So, that is more normal now. Perhaps a percentage point or something positive. I wouldn't want to speak about a big trend shift, but it's certainly not worse than Q4. But, it's a fairly stable and fairly low number. But, at least they are positive in a way in these regions that you mentioned, still, we feel that Europe is softer and a bit tougher. Um, and, and this, um, so this balance between the regions and Europe mix is a little bit weaker, whereas the others are somewhat on the positive side. So it's really hard to say, um, in terms of um, uh, cross-selling effect. These are, I think, you know, it's constant work kicking in. We do have some more specific segments where it's clearer, like we have mentioned before, the medical technology area where we cooperate very well across the companies and even the continents. Um, but, um, it's hard to break out that in this quarter with such low numbers, but it's positive at least. And I think that's what we should bring with us.

Unknown
27:48 - 28:04

All right. And on, uh, you talk about both growth and savings in your management agenda. Uh, what new savings initiatives? Uh, or on the, um, on the sort of table right now. I mean, you did something similar last year. Have you identified any new sort of avenues here?

Speaker 1
28:09 - 28:10

Uh, so, you know.

Unknown
28:10 - 28:11

There are.

Speaker 1
28:11 - 29:24

Several things going on in a big group. And, you know, we're working very in many ways decentralized. So it's, I would say, it's a general sort of cost consciousness, um, as the basis for everything. Uh, we do have certain initiatives we really try to get the companies together, for example, in procurement, um, uh, where, you know, these are times when you really need to work together to find the best deal. Um, uh, in terms of, I mean, I think what we did with Stumpf was quite, you know, it's not very often we do structural moves like that, uh, but, uh, definitely, you know, we are looking for opportunities, also related to the footprint and where to produce the product in the best way. Uh, but, uh, it's a little bit of just, you know, hard work, down in the subsidiaries and being cost conscious and right now but then as I said, you know, it is a balance because we do have some very interesting areas that we want to invest in and make sure we have salespeople. So, um, so it's, it's, it's a, it's really the balance that's trickier to manage at the same time.

Unknown
29:25 - 29:25

Later on. How?

Unknown
29:26 - 29:35

All right. Just finally, the mindset in minority interest, which subsidiaries primarily, just to remind us of the tax. That's it.

Unknown
29:38 - 29:39

I mean, which one?

Henrik
29:40 - 29:48

I don't know. I don't know if we, but it could be. There are some in biotech, in the satellite business, for example. Yeah.

Speaker 1
29:48 - 30:06

I mean, we have to go through all the press releases. You will see there is a minority stake in Alchemists. There is a minority stake in some of the biotech companies, like the satellite business, like in Finland, etc. Uh, so there are a few companies with a handful of companies with minority interests.

Unknown
30:06 - 30:09

That was just fairly big, but we can take it offline later. Thank you so much.

Unknown
30:09 - 30:12

Yeah, thanks.

Unknown
30:17 - 30:25

There are no more phone questions at this time, so I hand the conference back to the speakers for any written questions and closing comments.

Speaker 1
30:28 - 30:34

So thank you, everybody, for joining our webcast this morning. And, uh, wish you all a great day. Thank you very much.

Continue to the webcast
Lundbeck - Præsentation af delårsrapport for Q3 2026
Language: Danish11/12/2026, 12:00 PM
H. Lundbeck A/S ventes at offentliggøre sin delårsrapport for Q3 2026 den 11. november 2026. Dagen efter, den 12. november kl. 13.00, vil Jens Høyer, Vice President & Head of Investor Relations, præsentere resultaterne og svare på spørgsmål fra publikum i et live online event.
Wirtek - Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 10:00 AM
Wirtek is expected to release its Q3 2026 interim report on 11 November 2026. The next day at 11.00 CET, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session.
Rovsing - Præsentation af Interim Management Statement for Q1 2026/27
Language: Danish11/11/2026, 12:00 PM
Rovsing ventes at offentliggøre sin Interim Management Statement for Q1 2026/27 den 10. november 2026. Den 11. november kl. 13.00 vil ledelsen præsentere kvartalets tal, give en status på udviklingen i forretningen samt følge op på de seneste selskabsnyheder. Præsentationen efterfølges af en Q&A-session.
DADC - Præsentation af handelsopdatering for Q3 2026
Language: Danish11/5/2026, 8:30 AM
Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen. Danish Aerospace and Defence Company (DADC) ventes at offentliggøre sin handelsopdatering for 3. kvartal 2026 den 4. november 2026. Dagen efter, den 5. november kl. 09.30, vil selskabets CEO, Thomas A.E. Andersen, præsentere resultaterne samt svare på spørgsmål i et online live-event.
Boozt AB, Audiocast, Q3'26
Language: English11/3/2026, 8:30 AM
Herman Landin Thank you and good morning to all. Welcome to our Q3 2026 presentation. So, let's turn to the first slide, please. We will follow our usual agenda. I'll take you through the highlights a…
NORDEN – Presentation of Q3 2026
Language: English10/29/2026, 9:30 AM
NORDEN is expected to release its Q3 2026 results on 29th October 2026. The same day at 10.30am, management will present the results in an online event followed by a Q&A.
Agillic – Præsentation af kvartalsrapporten for Q3 2026
Language: Danish10/22/2026, 8:00 AM
Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen. Agillic offentliggør kvartalsrapporten for Q3 2026 den 22. oktober 2026. Samme dag kl. 10:00 vil selskabets CEO Christian Samsø præsentere resultaterne, gennemgå forventningerne til resten af 2026, give en opdatering på markedsforholdene og besvare spørgsmål ved et online live-event.
Nordea third-quarter results 2026
Language: English10/15/2026, 8:00 AM
Head of Investor Relations Good morning and welcome to Nordea's third-quarter 2026 results. Nordea's third-quarter 2026 results. I am your Head of Investor Relations. As usual, we will start with the…
GreenMobility - Presentation of the Q3 2026 Trading Statement
Language: English10/14/2026, 11:00 AM
GreenMobility is expected to release its Q3 2026 Trading Statement on 8 October 2026. On 14 October at 13:00 CEST, CEO Kasper Gjedsted will present the figures and answer questions in a live online event.
Rovsing – Præsentation af årsrapport 2025/26
Language: Danish9/28/2026, 9:00 AM
Rovsing ventes at offentliggøre årsrapporten for regnskabsåret 2025/26 den 25. september 2026. Den 28. september kl. 11.00 vil ledelsen præsentere årets resultater, give en status på udviklingen i forretningen samt kigge frem mod 2026/27. Præsentationen efterfølges af en Q&A-session
Danish Aerospace and Defence Company – Præsentation af H1 2026 resultater
Language: Danish8/25/2026, 8:00 AM
Danish Aerospace and Defence Company (DADC) ventes at offentliggøre selskabets rapport for H1 2026 den 24. august 2026. Dagen efter, den 25. august kl. 10.00, vil selskabets CEO, Thomas A.E. Andersen, præsentere resultaterne samt svare på spørgsmål i et online live-event.
North Media – Præsentation af regnskabet for 2. kvartal 2026
Language: Danish8/21/2026, 12:00 PM
Tilmeld dig North Media’s præsentation af regnskabet for 2. kvartal 2026 – fredag d. 21. august 2026 kl. 14.00. Se med når ledelsen i North Media gennemgår kvartalsregnskabet der offentliggøres dagen før, og hvordan første halvår af 2026 er forløbet, samt svarer på spørgsmål.
Wirtek – Presentation of Q2 2026 Interim Report
Language: English8/14/2026, 9:00 AM
Wirtek is expected to release its Q2 2026 interim report on 12 August 2026. Friday 14 August at 11.00 CEST, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session.
Boozt AB, Audiocast, Q2'26
Language: English8/14/2026, 7:30 AM
Herman Thank you. Good morning to all, and welcome to our Q2 2026 webcast. So let's turn to the first slide, the agenda for today's presentation. We will follow our usual agenda. I'll take you through…
NORDEN – Presentation of the quarterly report for Q2 2026
Language: English8/13/2026, 8:30 AM
NORDEN is set to release its quarterly report for Q2 2026 on the morning of Thursday 13 August 2026. On the same day at 10:30 AM, we are pleased to invite you to a presentation of the financial results with CEO Jan Rindbo and CFO Martin Badsted, who will also answer questions from the audience.
Sampo Oyj, Audiocast, Q2'26
Language: English8/12/2026, 7:30 AM
Mirko Hurmerinta Good morning, everyone, and welcome to Sampo Group's conference call on second quarter 2026 results. My name is Mirko Hurmerinta, the interim Head of IR at Sampo. I am joined on the c…
Nordea half-year results 2026 webcast
Language: English7/16/2026, 8:00 AM
Ilkka Good morning and welcome to Nordea's second quarter 2026 results. I am Ilkka, Head of Investor Relations. As usual, we'll start with the presentation by Group CEO Frank Vang-Jensen, followed by…
NORDEN – Presentation of the quarterly report for Q1 2026
Language: Danish5/6/2026, 8:30 AM
NORDEN is set to release their quarterly report for Q1 2026 on the morning of Wednesday 6 May 2026. On the same day at 10:30 AM, we are pleased to invite you to a presentation of the financial results with CEO Jan Rindbo and CFO Martin Badsted, who will also answer questions from the audience.
Sampo Oyj, Audiocast, Q1'26
Language: English5/6/2026, 7:30 AM
Mirko Hurmerinta Good morning, everyone, and welcome to Sampo Group's conference call on first quarter 2026 results. My name is Mirko Hurmerinta and I am the interim Head of Investor Relations at Samp…
Boozt AB, Audiocast, Q1'26
Language: English4/24/2026, 7:30 AM
Herman Good morning and welcome to our presentation of our Q1 2026 report. Let's just go to the agenda slide. We will have the usual agenda for the presentation. And I will present the highlights of t…